JP2014502729A - 再発性乳癌のタンパク質バイオマーカー - Google Patents

再発性乳癌のタンパク質バイオマーカー Download PDF

Info

Publication number
JP2014502729A
JP2014502729A JP2013547688A JP2013547688A JP2014502729A JP 2014502729 A JP2014502729 A JP 2014502729A JP 2013547688 A JP2013547688 A JP 2013547688A JP 2013547688 A JP2013547688 A JP 2013547688A JP 2014502729 A JP2014502729 A JP 2014502729A
Authority
JP
Japan
Prior art keywords
breast cancer
protein
proteins
peptides
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013547688A
Other languages
English (en)
Japanese (ja)
Inventor
デイビッド、ビー．クリッツマン
マーレーン、エム．ダーフラー
トーマス、ピー．コンラーツ
ブライアン、エル．フッド
ニコラス、ダブリュ．ベイトマン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Expression Pathology Inc
Original Assignee
Expression Pathology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Expression Pathology Inc filed Critical Expression Pathology Inc
Publication of JP2014502729A publication Critical patent/JP2014502729A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2013547688A 2010-12-29 2011-12-29 再発性乳癌のタンパク質バイオマーカー Pending JP2014502729A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061428145P 2010-12-29 2010-12-29
US61/428,145 2010-12-29
PCT/US2011/067996 WO2012092529A2 (fr) 2010-12-29 2011-12-29 Biomarqueurs protéiques de cancer du sein récurrent

Publications (1)

Publication Number Publication Date
JP2014502729A true JP2014502729A (ja) 2014-02-03

Family

ID=46383871

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013547688A Pending JP2014502729A (ja) 2010-12-29 2011-12-29 再発性乳癌のタンパク質バイオマーカー

Country Status (5)

Country Link
EP (1) EP2659272A4 (fr)
JP (1) JP2014502729A (fr)
AU (1) AU2011351990A1 (fr)
CA (1) CA2823334A1 (fr)
WO (1) WO2012092529A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014526682A (ja) 2011-09-12 2014-10-06 クリエイティクス エルエルシー 標的分子を検出する非侵襲的方法
JP6646571B2 (ja) * 2013-03-13 2020-02-14 クリエイティクス エルエルシー 膵臓がんを検出するための方法および組成物
CN104277102B (zh) * 2014-06-27 2017-04-12 李光辉 一种检测乳腺癌标志物Annexin A1抗原表位氨基酸序列及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007506426A (ja) * 2003-09-24 2007-03-22 オンコセラピー・サイエンス株式会社 乳癌を診断する方法
WO2010009368A2 (fr) * 2008-07-18 2010-01-21 Oragenics, Inc. Compositions pour la détection et le traitement du cancer colorectal

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006127861A2 (fr) * 2005-05-25 2006-11-30 Expression Pathology, Inc. Diagnostic de maladies et d'etats pathologiques par l'analyse d'echantillons biologiques traites par voie histopathologique a l'aide de preparations tissulaires liquides
JP5166250B2 (ja) * 2005-05-25 2013-03-21 エクスプレッション、パソロジー、インコーポレイテッド 組織病理学的に処理した生物学的試料からのプロテオームの適用範囲を増加させるための、液体組織標品を用いたマルチプレックス方法
WO2007048978A2 (fr) * 2005-10-28 2007-05-03 Biomerieux Sa Procede de detection du cancer
WO2007112350A2 (fr) * 2006-03-24 2007-10-04 Expression Pathology Méthode pour estimer l'état métastatique d'une tumeur primaire
WO2009126969A2 (fr) * 2008-04-11 2009-10-15 Expression Pathology Inc. Biomarqueurs pour maladie endométriale

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007506426A (ja) * 2003-09-24 2007-03-22 オンコセラピー・サイエンス株式会社 乳癌を診断する方法
WO2010009368A2 (fr) * 2008-07-18 2010-01-21 Oragenics, Inc. Compositions pour la détection et le traitement du cancer colorectal

Also Published As

Publication number Publication date
CA2823334A1 (fr) 2012-07-05
EP2659272A4 (fr) 2015-07-22
WO2012092529A2 (fr) 2012-07-05
WO2012092529A3 (fr) 2012-08-23
EP2659272A2 (fr) 2013-11-06
AU2011351990A1 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
JP6670288B2 (ja) 化学療法標的に対するｓｒｍアッセイ
EP3066474B1 (fr) Biomarqueurs du carcinome de la vessie
US20150005183A1 (en) Protein biomarkers of late stage breast cancer
US9766246B2 (en) SRM/MRM assay for subtyping lung histology
WO2008130887A1 (fr) Biomarqueurs du carcinome thyroïdien folliculaire et procédés d'utilisation de ceux-ci
WO2013036754A2 (fr) Procédés et compositions pour le diagnostic d'un cancer ovarien
EP3092495B1 (fr) Dosage srm pour pd-l1
CA2823337C (fr) Analyse par srm/mrm de proteines her3
EP2805346B1 (fr) Dosage srm/mrm pour la protéine du récepteur de l'insuline
JP2014502729A (ja) 再発性乳癌のタンパク質バイオマーカー
KR20200099108A (ko) 암의 진단용 조성물
JP2014513790A (ja) 後期乳癌のタンパク質バイオマーカー
WO2019242741A1 (fr) Biomarqueurs pour le carcinome urothélial et leurs applications
KR20210109724A (ko) 암의 진단용 조성물
KR102316892B1 (ko) 암의 진단용 조성물
US20150005182A1 (en) Protein biomarkers of recurrent breast cancer
US20230074311A1 (en) Composition for cancer diagnosis
US20150050665A1 (en) Predictive biomarkers for breast cancer
Reymond et al. Proteomics in lung cancer

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20141117

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20150812

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150814

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160126